CTRI/2020/07/026642招募中未知
Efficacy of Albumin plus Midodrine v/s albumin alone in reducing incidence of paracentesis induced circulatory dysfunctions in ACLF patients-A Randomized Controlled Trial.
试验速览
- 阶段
- 未知
- 状态
- 招募中
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
入选标准
- •ACLF patients (as per APASL definition) with grade II/III ascites
排除标准
- •1.Age < 18 or >75 years
- •2.Hepatocellular carcinoma
- •3.Extrahepatic portal vein obstruction
- •4.Non cirrhotic ascites
- •5.Serum creatinine >1.5mg/dl
- •6.Refractory septic shock
- •7.Beta blockersPortal vein thrombosis
- •8.Grade 3â??4 HE
- •9.Pregnancy or Lactation
- •10.Active variceal bleed
- •11.Respiratory, cardiac, renal failure
- •12.Uncontrolled hypertension
- •13.Severe coagulopathy
- •14.Refusal to participate
研究者
相似试验
招募中
3 期
Role of midodrine with albumin (drug) in Liver Disease with abdominal distentioCTRI/2023/10/059106Institute of Liver and Biliary Sciences
招募中
不适用
Evaluation of Albumin and Midodrine in Patients (drug) With Decompensated Cirrhosis (Liver Cirrhosis)CTRI/2021/04/032539Institute of Liver and Biliary Sciences
已完成
3 期
Albumin in heart surgery? Effect of Starch in valve heart surgeryIRCT20190512043568N1Ragaei heart center80
尚未招募
不适用
Evaluation of Low-dose Albumin and Midodrine Versus Midodrine Alone in Outcome of Recurrent Ascites in Patients With Decompensated Cirrhosis.Decompensated CirrhosisNCT06245590Institute of Liver and Biliary Sciences, India100
Unknown
不适用
Evaluation of Albumin and Midodrine Versus Albumin Alone in Outcome of Refractory Ascites in Patients With Decompensated Cirrhosis.Liver CirrhosisNCT04816240Institute of Liver and Biliary Sciences, India200